MedTrace Logo

Behavioural Therapy With Checklist for Overactive Bladder

NCT03662893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-09-10

No results posted yet for this study

Summary

The aim of this study is to investigate the efficiency of this newly-established checklist for overactive bladder (OAB) and whether determinate to adherence and persistence rate of combination of behavioural therapy and anticholinergic medications in patients with OAB.

Conditions

Interventions

BEHAVIORAL

behavioural therapy with written checklist form to complete

Behavioural therapy for overactive bladder such as advice on fluid balance, bladder retraining, urgency suppression or normal voiding techniques, pelvic floor muscle training, caffeine reduction, dietary changes, weight loss and other life style changes

DRUG

Antimuscarinic drugs used in overactive bladder

Antimuscarinic drugs (Tolterodine, solifenacin, propiverine, darifenacin,fesoterodine)

BEHAVIORAL

behavioural therapy with written guideline

behavioural therapy with written guideline,which are the same as those in the checklist

Sponsors & Collaborators

  • Ministry of Health, Turkey

    collaborator OTHER_GOV

  • Ankara Training and Research Hospital

    lead OTHER

Principal Investigators

  • Koray Agras, Prof · Ankara Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2017-12-31
Completion
2018-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03662893 on ClinicalTrials.gov